Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Myriad Genetics, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 37.83||$ 46.24|
|Low||$ 36.84||$ 30.30|
The current last sale of $37.15 is 22.61% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are one of the largest specialty molecular diagnostic laboratories in the world and since our founding in 1992, have tested over 1.5 million patients. We are headquartered in Salt Lake City, Utah and generated worldwide revenues of approximately $723 million during our fiscal year ended June 30, 2015. We are a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives through pioneering molecular diagnostics. Through our proprietary technologies, we believe we are positioned to identify important disease genes, the proteins they produce, and the biological pathways in which they are involved to better understand the genetic basis of human disease and the role that genes and their related proteins may play in the disease process. We believe that identifying biomarkers (DNA, RNA and proteins) will enable us to develop novel molecular diagnostic tests that can provide important information to solve unmet medical needs. ... More ...
Where does MYGN fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$1.45|
|Quarterly EPS Est:||0.38|